Education

PharmD, University of the Pacific,
MBA, University of San Francisco

Research Interests

• economic modeling
• quality of life evaluations in the areas of mental health and neurobiology
• health policy analyses
• drug benefit design

Courses Taught

• Pharm535/Hserv 584: Evaluating Outcomes in Health & Medicine
• Pharm 541: Health Care & Society
• Resident Seminar

Activities

Dr. Devine is a member of the American Association of Colleges of Pharmacy, American College of Clinical Pharmacy, Academy of Managed Care Pharmacy, Drug Information Association, and the International Society for Pharmacoeconomics and Outcomes Research. She was active for several years with the California Society of Health-System Pharmacists, where she supported legislation advancing collaborative drug therapy management for pharmacists. She currently serves on the executive committee of the Section of Clinical Specialists of the American Society of Health-System Pharmacists, where her efforts are in strengthening the role of the pharmacist in research.

Selected Publications

Erickson TN, Devine EB, O'Young T, Hanson L, French B, Brennan C. The impact on glycemic control of switching medically vulnerable patients with uncontrolled diabetes from NPH to glargine insulin in county hospital. (in press at American Journal of Health-System Pharmacy).

Devine, EB, Hakim Z, Greene J. A systematic review of patient reported outcomes instruments measuring sleep dysfunction in adults. Pharmacoeconomics 2005;23(9):889-912.

Devine EB, Beney J, Bero LA. Equity, accountability transparency: Successful use of the contributorship concept in a multi-site study. Am J Pharm Educ 2005;69(4): article 61.

Devine EB, Wilson-Norton JL, Lawless NM, Hazlet TK, Hansen R, Kelly K, Te S, Wong C. Preparing for computerized prescriber order entry by evaluating preimplementation medication errors. In Henrksen K, Battles JB, Mark ES, Lewin DI, eds. Advances in patient safety: from research to implememtation. Vol. 2, Concepts and methodology. AHRQ Publication No. 05-0021-2. Rockville, ME: Agency for Healthcare Research and Quality; Feb. 2005.

Wittkowsky Ak, Devine EB. Frequency of causes of over-and under-anticoagulation in patients treated with warfarin. Pharmacotherapy 2004;24(10):1311-1316.

Witkowsky AK, Whitely Ks, Devine EB, Nutescu E. Effect of age on international normalized ratio at the time of major bleeding in patients treated with warfarin. Pharmacotherapy 2004;2004; 24(5):600-605.

Devine EB, Smith Kl, Stehman-Breen C, Patrick DL. Health-related quality of life assessment in chronic kidney disease. Expert Rev Pharmacoeconomics Outcomes Res 2003;3(1):89-100.

Sullivan SD, Lew DP, Devine EB, Hakim Z, Reiber G, Veenstra DL. Health state preference assessment in diabetic peripheral neuropathy.Pharmacoeconomics 2002;20(15):1079-1089.

Beney J, Devine EB, Bero LA. Effect of telephone follow-up on the physical well-being dimension of qualityof life in patients with cancer. Pharmacotherapy 2002;22(10):1301-1311.

Devine EB, Kowdley KV, Veenstra DL, Sullivan SD.Management strategies for ribavarin-induced hemolytic anemia in the treatment of hepatitis C: clinical and economic implications
Value in Health 2001; 4(5):376-384

Brethauer B, Devine EB, Jue M, Quan D, Louie C.Cost-benefit analysis of a clinical pharmacist’s presence on a post-liver transplant service.
Hospital Pharmacy. 2000;Vol 35(11):1197-1202

Wilson L, Devine, EB, So K.Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema. Respiratory Medicine. 2000; Vol 94;204-213

Carmichael JM, O'Connell MB, Devine EB, Kelly HW, Ereshefsky L, Linn WD, Stimmel GL. Collaborative drug therapy management by pharmacists. ACCP Position Statement. Pharmacotherapy. 1997;17(5):1050-1061.

Research Associate Professor
(206) 221-5760
bdevine@u.washington.edu